Handa Pharmaceuticals Inc(TW:6620)
NT$125.50+11.00 (+20.10%)
TW:6620
Handa Pharmaceuticals Inc financials statements
NT$125.50
At close:+11.00 (+20.10%)
Handa Pharmaceuticals Inc (6620) Income Statement
Handa Pharmaceuticals Inc Income Statement
Last quarter (Q2 2026), Handa Pharmaceuticals Inc's total revenue was NT$211.95M, a decrease of 54.89% from the same quarter last year. In Q2, Handa Pharmaceuticals Inc's net income was NT$31.63M. See Handa Pharmaceuticals Inc’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 1.73B | NT$ 830.67M | NT$ 1.11B | NT$ 197.68M | NT$ 29.23M | |
| NT$ 1.46B | NT$ 829.50M | NT$ 1.11B | NT$ 178.97M | NT$ 27.77M | |
| NT$ 527.59M | NT$ 411.44M | NT$ 411.59M | NT$ 267.08M | NT$ 281.66M | |
| Depreciation and Amortization | NT$ 164.13M | NT$ 10.43M | NT$ 12.44M | NT$ 15.18M | NT$ 35.16M |
| NT$ 1.10B | NT$ 490.09M | NT$ 802.78M | NT$ -27.69M | NT$ -225.41M | |
| NT$ 934.18M | NT$ 418.06M | NT$ 693.43M | NT$ -88.12M | NT$ -253.88M | |
| NT$ 2.79M | NT$ 61.11M | NT$ 99.06M | NT$ 44.97M | NT$ -6.92M | |
| NT$ 936.98M | NT$ 479.17M | NT$ 792.49M | NT$ -43.15M | NT$ -260.80M | |
| NT$ 749.77M | NT$ 472.74M | NT$ 726.89M | NT$ -40.01M | NT$ -247.67M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 4.85 | NT$ 3.37 | NT$ 5.41 | NT$ -0.32 | NT$ -2.07 |
| Diluted EPS | NT$ 4.85 | NT$ 3.35 | NT$ 5.40 | NT$ -0.32 | NT$ -2.07 |
| Weighted Average Shares Outstanding | 154.59M | 140.48M | 134.30M | 125.56M | 119.58M |
| Weighted Average Shares Outstanding (Diluted) | 154.59M | 141.09M | 134.72M | 125.56M | 119.58M |
Currency in TWD
